Key facts
- This page summarizes Stephen J. Carriere's Form 4 filing for Evelo Biosciences, Inc..
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 23 Jan 2023, 16:35.
Stephen J. Carriere - 19 Jan 2023 Form 4 Insider Report for Evelo Biosciences, Inc.
- Reporting relationship
- Principal Accounting Officer
- Issuer ticker
- N/A
- Reported as of
- 19 Jan 2023
- Net transaction value
- -$160
- SEC form
- 4
- Accepted by SEC
- 23 Jan 2023, 16:35:06 UTC
- Prior SEC filing
- 21 Jan 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stephen J. Carriere
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Stephen J. Carriere filed Form 4 for Evelo Biosciences, Inc. on 23 Jan 2023.
Change
- Previous filing in this sequence was filed on 21 Jan 2022.
- Current net transaction value: -$160.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EVLO
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +354
- Change %
- Price
- Shares after
- 354
- Date
- 19 Jan 2023
- Ownership
- Direct
- Footnotes
- F1, F2
EVLO
transaction
Common Stock
Sale
- Transaction value
- $160
- Shares
- -151
- Change %
- -43%
- Price
- $1.06
- Shares after
- 203
- Date
- 23 Jan 2023
- Ownership
- Direct
- Footnotes
- F3, F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EVLO
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -354
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 1,063
- Date
- 19 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 354
- Exercise price
- $0.000000
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Settlement of shares of Common Stock acquired upon the vesting of Restricted Stock Units previously granted to the reporting person.
Footnote F2
The price is N/A.
Footnote F3
The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units previously granted to the reporting person. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
Footnote F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $1.06 to $1.0712, inclusive. The reporting person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.
Footnote F5
The Restricted Stock Units vest in four substantially equal annual installments at the end of each annual anniversary of the date of grant, subject to continued employment on such dates.